Max Slim Alpha-GPC + Citicoline: The affected lot contains an undeclared ingredient (caffeine)
Brand(s)
Last updated
Summary
Product
Max Slim Alpha-GPC + Citicoline
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|
| Max Slim Alpha-GPC + Citicoline | NPN 80129088 | Capsule | Cytidine 5'-(trihydrogen diphosphate) P'-[2-(trimethylammonio)ethyl] ester inner salt 400mg L-alpha-Glycerophosphorylcholine 400mg | G9P12C24 |
Issue
The affected lot contains an undeclared ingredient (caffeine).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Maximum Slim
2114 N. Flamingo Rd #202
Pembroke Pines, FL
33028, USA
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Recall date
Identification number
RA-81910
Get notified
Receive emails about new and updated recall and safety alerts.